Board, Management Appointment

RNS Number:1309H
Spacelabs Healthcare Inc.
06 November 2007


Spacelabs Healthcare Announces Board and Management Appointments

HAWTHORNE, CA -- (MARKET WIRE) -- 11/06/07 -- Spacelabs Healthcare,
Inc. (LSE: SLAB) today announced the appointment of Mr. Joseph Davin,
Group President North American Operations, and Mr. Nicholas Ong,
Group President Emerging Market Operations, to the Board of
Directors.

Spacelabs also announces that Mr. Nikhil Mehta has submitted his
resignation as a Director and as Chief Financial Officer, effective
January 21, 2008, at which time he intends to pursue other
professional opportunities. In addition, Mr. Dave Tilley has also
submitted his resignation as a Director. Mr. Tilley will continue to
serve as the company's Chief Operating Officer primarily
concentrating on the opening of the Company's new manufacturing
facility in China.

Deepak Chopra, Spacelabs Healthcare's CEO, stated, "We would like to
welcome Joe and Nicholas to the Board of Directors. We believe that
both Joe and Nicholas will be great additions to the board due to
their extensive industry experience and the critical roles that they
currently play within the Company. The Board would also like to
express its appreciation to Nikhil Mehta for his service and
dedication and wish him the best of luck in his future endeavors."

Mr. Davin, age 52, Group President North American Operations, is
currently responsible for sales, marketing and customer support teams
for the U.S. and Canadian channels. Additionally, he is in charge of
the product development and global marketing for the Patient
Monitoring and Connectivity product group. He has been with Spacelabs
Healthcare for 15 years prior to which he served as the General
Manager for the Critical and Emergency Care division of Datex-Ohmeda.
He has over 25 years experience in the medical equipment industry.
Mr. Davin holds a Bachelor of Science degree in Biology from Bates
College.

Mr. Ong, age 42, Group President Emerging Market Operations, is
currently responsible for the sales, marketing, service, product
development and customer support teams for the Asia/Pacific, India
and Latin America channels. Prior to this appointment, Mr. Ong was
responsible for the Anesthesia Delivery & Ventilation product group
and Spacelabs Medical strategic marketing and business development.
He previously served as President for Asia Pacific for Datex-Ohmeda
and has 19 years of experience in the diagnostics and medical
equipment industry. Mr. Ong holds a Bachelor of Science degree from
the University of California at Berkeley and an MBA from the Henley
Management College.

There are no other matters which are required to be announced with
regard to these appointments under paragraph (g) of schedule 2 of the
AIM rules.

About Spacelabs Healthcare, Inc.

Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) is an
international developer, manufacturer and distributor of medical
equipment and services including patient monitoring solutions,
anesthesia delivery and ventilation systems, pulse oximeters and
sensors and bone densitometers selling to hospitals, clinics and
physicians offices. Additionally, the Company provides ECG
laboratory services to pharmaceutical companies undertaking clinical
trials, whereby patient ECG data is recorded, analyzed, tabulated and
interpreted.

The Company has established brand names in both medical devices and
medical services such as "Spacelabs," "Blease" and "Del Mar Reynolds."
 The Company employs approximately 1,050 personnel in its 14 offices
in UK, Canada, France, Germany, Finland, India, Singapore and the
United States.

This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. Such
statements include information regarding the Company's expectations,
goals or intentions about the future. The actual results may differ
materially from those described in or implied by any forward-looking
statement. Other important factors are set forth in the Securities
and Exchange Commission filings of OSI Systems, Inc. All
forward-looking statements speak only as of the date made, and the
Company undertakes no obligation to update these forward-looking
statements.

For Further Information
Spacelabs Healthcare, Inc.
Jeremy Norton - Director, Investor Relations
12525 Chadron Ave
Hawthorne CA 90250
(310) 349 2372

Piper Jaffray Ltd.
David Rasouly
Jamie Adams
Tel: 020 3142 8700




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
BOAEASFKEEKXFFE
Spacelabs Healthcare (LSE:SLAB)
過去株価チャート
から 5 2024 まで 6 2024